← Scroll for more →
Ani Pharmaceuticals Inc (ANIP)
Pharmaceutical Preparations
Latest Price
$73.16
TTM P/E
15.90
Normalized P/E
643.54
TTM Div Yield
--
Fwd Div Yield
--
Book Value
28.39
P/B Ratio
2.58
Valuation metrics
adjust assumptions →EPS: $3.32
Book value / share: $24.04
Formula: √(22.5 × EPS × BVPS)
Graham Number
$42.38
41% downside
Base FCF: $79M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$14.67
80% downside
EPS: $3.32
Target P/E: 16×
Formula: EPS × P/E
P/E Fair Value
$53.12
26% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.96M | $244.0M | 14.06% | +211.2K | 2026-06-30 |
| Soleus Capital Management, L.P. | 867.8K | $71.0M | 4.13% | +47.5K | 2026-06-30 |
| Vanguard Capital Management LLC | 838.2K | $69.0M | 3.98% | +15.2K | 2026-06-30 |
| State Street Corp | 831.6K | $68.0M | 3.95% | +60.1K | 2026-06-30 |
| Tang Capital Management LLC | 707.5K | $58.0M | 3.36% | -- | 2026-06-30 |
| Dimensional Fund Advisors LP | 623.5K | $51.0M | 2.96% | +92.3K | 2026-06-30 |
| American Century Companies Inc | 574.5K | $47.0M | 2.73% | +382.9K | 2026-06-30 |
| Arrowstreet Capital, Limited Partnership | 562.0K | $46.0M | 2.67% | -2.3K | 2026-06-30 |
| Global Alpha Capital Management Ltd. | 558.0K | $46.0M | 2.65% | +196.8K | 2026-06-30 |
| Geode Capital Management, LLC | 536.4K | $44.0M | 2.55% | +47.2K | 2026-06-30 |